The literature provides conflicting information on whether the motion of the stapes footplate is piston-like or some other type of motion, such as rotational or rocking. Examination of the three-dimensional (3D) motion of the stapes footplate appears to be an excellent way to understand this complicated motion. Five microsphere reflective targets were placed on the stapes footplate in ten fresh human cadaver temporal bone preparations, and their vibration measured through an extended facial recess approach using a laser Doppler vibrometer. The five target sites on the stapes footplate were center, anterior, posterior, superior and inferior. The stimulus was a sound input of 80–120 dB SPL at the tympanic membrane over a frequency range of 0.1 to 10 kHz. The 3D motion of the stapes footplate was calculated using the velocity amplitude and phase obtained for each target. For frequencies up to 1.0 kHz the vibration of the stapes footplate was primarily piston-like; this motion became complex at higher frequencies, with rotary motion along both the long and short axis of the footplate. When the cochlea was drained, stapes footplate motion became essentially piston-like for all frequencies.

1.
Aibara R, Welsh JT, Puria S, Goode RL: Human middle-ear sound transfer function and cochlear input impedance. Hear Res 2001;152:100–109.
2.
Békésy G: Experiments in Hearing. New York, McGraw-Hill, 1960.
3.
Decraemer WF, Khanna SM: Modeling the malleus vibration as a rigid body motion with one rotational and one translational degree of freedom. Hear Res 1994;72:1–18.
4.
Decraemer WF, Khanna SM: New insights into vibration of the middle ear; in Rosowski JJ, Merchant SN (eds): The Function and Mechanics of Normal, Diseased and Reconstructed Middle Ears. The Hague, Kugler, 2000, pp 23–38.
5.
Decraemer WF, Khanna SM, Funnell WR: Malleus vibration mode changes with frequency. Hear Res 1991;54:305–318.
6.
Goode RL, Nakamura K, Gyo K, Aritomo H: Comments on ‘Acoustic transfer characteristics in human middle ears studied by a SQUID magnetometer method’ in J Acoust Soc Am 1987;82:1646–1654. J Acoust Soc Am 1989;86:2446–2449.
7.
Goode RL, Killion M, Nakamura K, Nishihara S: New knowledge about the function of the human middle ear: Development of an improved analog model. Am J Otol 1994;15:145–154.
8.
Guinan JJ Jr, Peake WT: Middle-ear characteristics of anesthetized cats. J Acoust Soc Am 1967;41:1237–1261.
9.
Gundersen T, Hogmoen K: Holographic vibration analysis of the ossicular chain. Acta Otolaryngol 1976;82:16–25.
10.
Gyo K, Aritomo H, Goode RL: Measurement of the ossicular vibration ratio in human temporal bones by use of a video measuring system. Acta Otolaryngol 1987;103:87–95.
11.
Hato N, Welsh JT, Goode RL, Stenfelt S: Acoustic role of the buttress and posterior incudal ligament in human temporal bones. Otolaryngol Head Neck Surg 2001;124:274–278.
12.
Heiland KE, Goode RL, Asai M, Huber AM: A human temporal bone study of stapes footplate movement. Am J Otol 1999;20:81–86.
13.
Huber A, Linder T, Ferrazzini M, Schmid S, Dillier N, Stoeckli S, Fisch U: Intraoperative assessment of stapes movement. Ann Otol Rhinol Laryngol 2001;110:31–35.
14.
Kirikae I: The Structure and Function of the Middle Ear. Tokyo, University of Tokyo Press, 1960.
15.
Lord RM, Abel EW, Wang Z, Mills RP: Effects of draining cochlear fluids on stapes displacement in human middle-ear models. J Acoust Soc Am 2001;110:3132–3139.
16.
Merchant SN, Ravicz MR, Rosowski JJ: Acoustic input impedance of the stapes and cochlea in human temporal bones. Hear Res 1996;99:30–45.
17.
Nishihara S, Aritomo H, Goode RL: Effect of changes in mass on middle ear function. Otolaryngol Head Neck Surg 1993;109:899–910.
18.
Söderström T, Stoica P: System Identification. New York, Prentice Hall, 1989.
19.
Vlaming MSM, Feenstra L: Studies on the mechanics of the normal human middle ear. Clin Otolaryngol 1986;11:353–365.
20.
Voss SE, Rosowski JJ, Merchant SN, Peake WT: Acoustic responses of the human middle ear. Hear Res 2000;150:43–69.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.